van der Wijngaart, Hanneke; Hoes, Louisa R; van Berge Henegouwen, J Maxime; van der Velden, Daphne L; Zeverijn, Laurien J; Roepman, Paul; van Werkhoven, Erik; de Leng, Wendy W J; Jansen, Anne M L; Mehra, Niven; Robbrecht, Debbie G J; Labots, Mariette; de Groot, Derk Jan A; Hoeben, Ann; Hamberg, Paul; Gelderblom, Hans; Voest, Emile E; Verheul, Henk M W
(American Association for Cancer Research Inc., 2021-11-15)
Purpose: To assess the efficacy of olaparib, a PARP inhibitor (PARPi) in patients with tumors with BRCA1/2 mutations, regardless of histologic tumor type. Patients and Methods: Patients with treatment-refractory BRCA1/2-mutated ...